Key breast cancer prognostic markers, such as PGR (t test P = 0.168; fold change = 0.76) and ERBB2 (t test P = 0.123; fold change = 1.23), showed no change between the two patient categories. This evidence concerns the gene ERBB2 and breast carcinoma.